# The Immune Response of Breast Cancer Patients Treated With Levobupivacaine Using Paravertebral or Superficial Chest Blocks

> **NCT05816538** · NA · ACTIVE_NOT_RECRUITING · sponsor: **University of Rijeka** · enrollment: 100 (estimated)

## Conditions studied

- Paravertebral Block
- Pectoralis and Serratus Plane Nerve Blocks
- Breast Cancer
- Immunologic Suppression
- Levobupivacaine

## Interventions

- **PROCEDURE:** Paravertebral nerve block (PVB)
- **PROCEDURE:** Pectoralis and Serratus Plane Nerve Blocks (PECS 2)
- **DEVICE:** Regional anesthetic technique with ultrasound guidance
- **DEVICE:** Regional anesthetic technique with peripheral nerve stimulation.
- **DRUG:** Levobupivacaine 0.5%
- **PROCEDURE:** General anesthesia

## Key facts

- **NCT ID:** NCT05816538
- **Lead sponsor:** University of Rijeka
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-01-18
- **Primary completion:** 2025-05
- **Final completion:** 2025-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05816538

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05816538, "The Immune Response of Breast Cancer Patients Treated With Levobupivacaine Using Paravertebral or Superficial Chest Blocks". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05816538. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*